CAS No.: 550368-41-7
PNRI-299 Catalog No. CSN18329
PNRI-299 is a selective AP-1 transcription inhibitor with IC50 of 20 μM without affecting NF-kappaB transcription (up to 200 μM) or thioredoxin (up to 200 μM).
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Souza DG, Vieira AT, et al. NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury. Br J Pharmacol. 2005 May;145(2):246-54.
- [2] Nguyen C, Teo JL, et al. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1169-73.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 550368-41-7 | 储存条件 |
|
|
| 分子式 | C21H15N5O4 | 运输 | 蓝冰 | |
| 分子量 | 401.37 | 别名 |
